ArticleFrontiers in neurology2025
Association between HALP score and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: insights from a large cohort study.
Article in Frontiers in neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Machine learning model for unfavorable outcome prediction in neurosurgical patients: the potential role of liver function markers.Frontiers in neurology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The HALP (hemoglobin, albumin, lymphocyte, and platelet) score is a newly emerging index for reflecting the systemic inflammation and nutritional status of patients. Previous studies have identified that HALP score is associated with clinical outcomes of various diseases. This study aims to explore the relationship between HALP score and clinical outcomes in patients with aneurysmal subarachnoid hemorrhage (aSAH). Methods: A total of 748 aSAH patients were included in this study. Patients were divided into tertiles based on their HALP score levels. At 90 days after discharge, patients received follow up and the modified Rankin Scale (mRS) was used to assess the functional outcome. Unfavorable functional outcome was defined as mRS ≥ 3. Multivariate logistic regression for poor functional outcome and postoperative complications was performed to explore the association between HALP score and clinical outcomes of aSAH patients, with adjustment for age, sex, and other important factors. Results: Compared to patients with a high HALP score, patients with a low HALP score tended to be female, had a higher Hunt Hess score, and had higher levels of glucose and creatine. After adjusting several potential confounding factors, multivariate logistic regression showed that patients with a low HALP score had a higher risk of unfavorable functional outcome (OR, 0.095, 95%CI: 0.056-0.163, Conclusion: Given that HALP score may contribute to identify aSAH patients at high risk for poor prognosis, these findings hold significant clinical relevance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.